Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Evaluating postoperative outcomes in patients with liver, bile duct, and pancreatic cancer using the inBody test

Official title: Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Run by Kochi University · NCT05257434 · Data updated 2026-11-12

This study is testing if using the inBody test to measure body composition can help doctors understand how well patients recover after surgery for liver, bile duct, and pancreatic cancer.

More Breast Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment1000 (estimated)
SponsorKochi University
Academic / other
Locations1 site (Kochi)
StatusRecruiting
StartedJanuary 1, 2019
Main results expectedJanuary 31, 2025
Study endsJanuary 31, 2030
Registry record updatedFebruary 25, 2022
Trial IDNCT05257434 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have undergone surgical treatment for hepato-biliary-pancreatic cancer.

Probably not a fit

Patients who have experienced significant weight loss prior to surgery, have distant metastases, or have severely impaired organ function may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses postoperative outcomes in patients who have undergone surgery for hepato-biliary-pancreatic cancer by utilizing the inBody test, which measures body composition. The study aims to identify correlations between body composition metrics and recovery outcomes post-surgery. By analyzing data from surgically treated patients, the research seeks to provide insights into how body composition may influence recovery and overall health after surgery.

Why it matters

Potential benefit: If successful, this study could help tailor postoperative care and improve recovery strategies for patients with hepato-biliary-pancreatic cancer.

How similar studies have gone: While the use of body composition analysis in postoperative outcomes is gaining interest, this specific approach using the inBody test in this cancer population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* surgically treated patients

Exclusion Criteria:

* a body weight loss of \>10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Where it's running

  • Takehiro Okabayashi
    Kochi, Japan
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.